Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics Inc
WKN: A2AP32 / Symbol: PTGX / Name: Protagonist / Aktie / Micro Cap /
77,50 €
-4,32 %
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $62.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $51.00 to $53.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at HC Wainwright from $50.00 to $54.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $54.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $53.00 to $57.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $54.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at BMO Capital Markets from $62.00 to $72.00. They now have an "outperform" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at Truist Financial Co. from $60.00 to $76.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "outperform" rating re-affirmed by analysts at Wedbush.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $70.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Citigroup Inc.. They set a "buy" rating and a $72.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "outperform" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $73.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics (NASDAQ:PTGX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Ratings data for PTGX provided by MarketBeat
Protagonist Therapeutics (NASDAQ:PTGX) is now covered by analysts at Barclays PLC. They set an "overweight" rating and a $72.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Neueste Beiträge
JPMorgan_Chase___Co_ in Atricure Inc. diskutieren